Pharming Group Competitors and Similar CompaniesClear all
Protalix BioTherapeutics's competitors and similar companies include Five Prime Therapeutics and Ambrx.
 Protalix BioTherapeutics Protalix is a biopharmaceutical company focused on the development, production, and commercialization of recombinant therapeutic proteins. |  Five Prime Therapeutics Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies. |  Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. | |
Founding Date | Founding Date 1994 | Founding Date 2001 | Founding Date 2003 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Karmiel, IL HQ | Locations South San Francisco, US HQ | Locations San Diego, US HQ |
Employees | Employees 213 | Employees 5141% decrease | Employees 70 |
Financial | |||
Revenue (est.) | Revenue (est.) $52.7m (FY, 2025) | Revenue (est.) $13.2m (FY, 2020) | Revenue (est.) $7.4m (FY, 2022) |
Net income | Net income ($6.6m) (FY, 2025) | Net income ($84.3m) (FY, 2020) | Net income ($78m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 62.5m | Total funding raised $ 237.2m | Total funding raised $ 347.9m |
For sources of this data, please see the company profile
View Company Profiles
Five Prime Therapeutics
HQ
South San Francisco, US
Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.
View companyAmbrx
HQ
San Diego, US
Employees
70
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
View company